See What HealthDay Can Do For You
Contact Us

Salvianolic Acid B Suppress Maturation of Dendritic Cells

Sal B effects on human monocyte-derived dendritic cell maturation blocked by PPARγ siRNA

FRIDAY, Dec. 2 (HealthDay News) -- Salvianolic acid B (Sal B) -- a herb-derived, water-soluble antioxidant known to help prevent atherosclerosis -- effectively suppresses the maturation of human monocyte-derived dendritic cells (h-monDCs), according to a study published in the December issue of the British Journal of Pharmacology.

Aijun Sun, M.D., Ph.D., from Fudan University in Shanghai, China, and colleagues investigated whether the anti-atherosclerotic effect of Sal B is mediated by suppressing h-monDC maturation. Purified human monocytes were incubated with granulocyte macrophage-colony stimulating factor and interleukin (IL)-4 to derive h-monDCs. The h-monDCs were stimulated by oxidized low-density lipoprotein (ox-LDL) in the presence or absence of peroxisome proliferator-activated receptor-γ (PPARγ) small interfering RNA (siRNA), after being pre-incubated with or without Sal B. Fluorescence-activated cell sorting was used to analyze the expression of h-monDC membrane molecules (CD40, CD86, CD1a, HLA-DR), an enzyme linked immunosorbent assay measured the cytokines, and Western blotting was used to determine the Toll-like receptor (TLR) 4-associated signalling pathway.

The investigators found that ox-LDL had multiple effects, including promotion of h-monDC maturation; stimulation of CD40, CD86, CD1a, and HLA-DR expression; production of IL-12, IL-10, and tumor necrosis factor-alpha; and up-regulation of TLR4 signalling. Sal B inhibited these effects. PPARγ activation, promotion of PPARγ nuclear translocation, attenuation of ox-LDL-induced up-regulation of TLR4 and myeloid differentiation primary-response protein 88, and inhibition of the downstream p38-mitogen activated protein kinase signalling cascade were also mediated by Sal B. These effects of Sal B were blocked by knocking down PPARγ with the corresponding siRNA.

"The possible anti-atherosclerotic effects of Sal B might be mediated by suppressing maturation of h-monDC," the authors write.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.